Synaptogenix Inc (SNPX)

[runncoach]

First read is you are correct. There is nothing presented today that contradicts the 20 ug dose as having a positive trend towards cognitive improvement just as the chief science officer of the alzheimer's association stated when top line results were announced. Company needs to get out and sell themselves better so shareholders know what to expect and when and how they can make byrostatin even better and longer lasting for patients IMO.